Journal Club: The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial

Summary

Availability:

On-Demand

Cost:

FREE

Create Account

Recommended

An Evolving Frontier: Endometrial Cancer Treatment

FREE

Phase II PICCOLO Trial Results

Results of Phase II PICCOLO Trial are available. Dr. Angeles Alvarez Secord, PI of PICCOLO Trial, and Dr. Wendel Naumann discuss results of MIRV in Recurrent Platinum-Sensitive Ovarian Cancer with High Folate Receptor-Alpha Expression.

FREE

Emerging data in platinum resistance advanced ovarian cancer

FREE

Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications

FREE

Radical Hysterectomy - Surgical Film Festival

$0.00 - $50.00

Journal Club: Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer

FREE

IGCS 2024 Endometrial Cancer Master Session

FREE

Journal Club - Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB–IVA

FREE

IGCS 2024 Cervical Master Sessions: Moving Forwards

FREE